← Eichor
Study identifier: NCT07599072 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

PREdiabetes GLycemic Impact and Data Evaluation

Condition: Pre Diabetic · Obesity & Overweight · Insulin Resistance  ·  Sponsor: Nazarii Kobyliak

PhaseNA
Planned participants80
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This prospective, randomized controlled trial evaluates whether real-time continuous glucose monitoring (CGM) improves glycemic control and lifestyle adherence in adults with prediabetes compared to conventional self-monitoring methods over a 3-month period. By analyzing metabolic markers and behavioral data, the study aims to determine the effectiveness of 24-hour monitoring as a personalized tool that increases patient adherence to lifestyle changes compared to conventional SMBG methods.

This description comes directly from the study's public registry record.

Talk to the study team

Nazarii Kobyliak, Professor  ·  +380442356005  ·  nazariikobyliak@gmail.com

Ilona Rudneva, Dr  ·  0442356005  ·  ilonarudneva57@gmail.com

Always discuss trial participation with your own doctor first.

Locations (3)

Bogomoletz Institute of PhysiologyKyiv, UkraineEnrolling By Invitation
Bogomolets National Medical UniversityKyiv, UkraineRecruiting
University Hospital of Bogomolets National Medical UniversityKyiv, UkraineRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07599072